TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12016346

Group type: EXPERIMENTAL
Intervention: Diffuse Muscular Coactivation (DMC) in fibromyalgia sufferers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Median frequency measurement
Number of subjects: 0
Study: 9685826

Group type: EXPERIMENTAL
Intervention: CT-guided fine-needle aspiration (CTNAB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transbronchial fluoroscopy-guided needle aspiration (TBNA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CTNAB
Number of subjects: 30

Group type: COMPARATOR
Intervention: TBNA
Number of subjects: 30
Study: 7911736

Group type: EXPERIMENTAL
Intervention: Cladribine 4 mg/m2/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cladribine 6 mg/m2/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cladribine 8 mg/m2/day
Number of subjects: 18
Study: 2899509

Group type: EXPERIMENTAL
Intervention: xamoterol 200 mg twice daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 31931098

Group type: EXPERIMENTAL
Intervention: Sildenafil therapy
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Lower eGFR
Number of subjects: 212
Study: 30695908

Group type: EXPERIMENTAL
Intervention: Collagen matrix (CM)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Free gingival graft (FGG)
Number of subjects: 19
Study: 28315160

Group type: EXPERIMENTAL
Intervention: L-carnitine (LC) at 2.0 g kg-1 of the diet for 4 weeks prior to MCLR injection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: L-carnitine (LC) at 1.0 g kg-1 of the diet for 4 weeks prior to MCLR injection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: L-carnitine (LC) at 0.5 g kg-1 of the diet for 4 weeks prior to MCLR injection
Number of subjects: 5

Group type: COMPARATOR
Intervention: MCLR intraperitoneal injection (150 μg kg-1 BW)
Number of subjects: 5
Study: 26289437

Group type: EXPERIMENTAL
Intervention: Combination of tastants (quinine, rebaudioside A, monosodium glutamate)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Umami tastant
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (tap water)
Number of subjects: 15
Study: 24139765

Group type: EXPERIMENTAL
Intervention: Counseling plus commitment contract, team incentives, and text message reminders for smoking cessation at 3 months
Number of subjects: 201

Group type: COMPARATOR
Intervention: Counseling (control group)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Counseling plus commitment contract, team incentives, and text message reminders for smoking cessation at 6 months
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Counseling plus commitment contract, team incentives, and text message reminders for smoking cessation at 14 months
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 201
Study: 21256876

Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine (2 doses)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo (1 dose)
Number of subjects: 375
Study: 19690450

Group type: EXPERIMENTAL
Intervention: Bathing with clear water twice weekly (Group B)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Washing with a washcloth moistened with clear water twice weekly (Group W)
Number of subjects: 57
Study: 17035091

Group type: EXPERIMENTAL
Intervention: Filtered plasma
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whole blood and RBC
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Plasma and RBC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unfiltered plasma
Number of subjects: 24
Study: 12819161

Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Preterm infants
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Term SGA infants
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Weight at 6 weeks of age
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Maternal smoking
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: General weaning practices
Number of subjects: 2000
Study: 11097666

Group type: EXPERIMENTAL
Intervention: Air group (2 mL of air)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Saline group (2 mL of 0.9% saline)
Number of subjects: 160
Study: 9357887

Group type: COMPARATOR
Intervention: Alfentanil at 0 ng/ml
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alfentanil at 25 ng/ml
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alfentanil at 50 ng/ml
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alfentanil at 100 ng/ml
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alfentanil administration
Number of subjects: 6
Study: 8211353

Group type: EXPERIMENTAL
Intervention: Aggressive therapy for myocardial ischemia and infarction in elderly patients
Number of subjects: 0
Study: 3609435

Group type: EXPERIMENTAL
Intervention: Ham's F10 supplemented with cord serum
Number of subjects: 321

Group type: COMPARATOR
Intervention: Menezo B2 used without serum
Number of subjects: 321
Study: 28956535

Group type: EXPERIMENTAL
Intervention: Immediate implants with platelet rich fibrin (PRF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Immediate implants without PRF (control)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Immediate implants with PRF
Number of subjects: 17
Study: 29084304

Group type: EXPERIMENTAL
Intervention: Silicone-based denture liners
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acrylic resin-based denture liners
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (acrylic resin)
Number of subjects: 30
Study: 25346382

Group type: EXPERIMENTAL
Intervention: Post-traumatic growth (PTG)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Single, life-altering stressful life event (SLE)
Number of subjects: 564
Study: 23116485

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketoconazole (400 mg) with FF/VI (200/25 μg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20613477

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 18847427

Group type: EXPERIMENTAL
Intervention: Mycophenolic acid (MPA) in the induction phase
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Rituximab and MPA in the induction phase (14 days)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Plasma exchanges
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Low-dose corticoids
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Dexamethasone and melphalan
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Eprosidate
Number of subjects: 268

Group type: COMPARATOR
Intervention: Anti-TNF-alpha agents
Number of subjects: 268
Study: 20204652

Group type: COMPARATOR
Intervention: 40,000 IU of vitamin D per week for 1 year
Number of subjects: 10229

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 10229
Study: 15832833

Group type: EXPERIMENTAL
Intervention: Risk reduction counselling
Number of subjects: 35
Study: 12018902

Group type: EXPERIMENTAL
Intervention: K-ras mutations in colorectal cancer samples from Israel
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison of K-ras mutations in colorectal cancer in Israel with other countries
Number of subjects: 105
Study: 9669829

Group type: EXPERIMENTAL
Intervention: OKY-046
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8067563

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 56
Study: 2968263

Group type: EXPERIMENTAL
Intervention: doxifluridine 4000 mg/m2
Number of subjects: 52

Group type: COMPARATOR
Intervention: fluorouracil 450 mg/m2 i.v.
Number of subjects: 52
Study: 31216000

Group type: EXPERIMENTAL
Intervention: Maternal and child 5‐year serum PFAS concentrations
Number of subjects: 80

Group type: COMPARATOR
Intervention: PFASs measured at ages 7 to 13 years
Number of subjects: 80
Study: 28364493

Group type: EXPERIMENTAL
Intervention: Melatonin treatment (N = 26)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Bright light therapy (N = 30)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (N = 28)
Number of subjects: 84
Study: 26567275

Group type: EXPERIMENTAL
Intervention: Treadmill-only supervised exercise training (SET) for 12 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination of treadmill and lower-limb resistance supervised exercise training (SET) for 12 weeks
Number of subjects: 35
Study: 25123230

Group type: EXPERIMENTAL
Intervention: internet-based self-help problem solving treatment (PST) for affective symptoms
Number of subjects: 286

Group type: COMPARATOR
Intervention: waiting list control group
Number of subjects: 286
Study: 22365697

Group type: EXPERIMENTAL
Intervention: Treatment with 20 mg/kg body weight oxytetracycline intramuscular, 4% lotagen intrauterine, and 500 μg cloprostenol intramuscular.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treatment with 20 mg/kg body weight oxytetracycline intramuscular, 4% lotagen intrauterine, and 500 μg cloprostenol intramuscular, based on bursal size.
Number of subjects: 60
Study: 19732200

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard dose chemotherapy (SC)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Incremental cost-effectiveness ratio
Number of subjects: 21
Study: 17101267

Group type: EXPERIMENTAL
Intervention: Expanding collagen tablets
Number of subjects: 12

Group type: COMPARATOR
Intervention: Small sustained release hydrocolloid tablets
Number of subjects: 12
Study: 15010336

Group type: EXPERIMENTAL
Intervention: 6‐h continuous infusion of [1,2‐(13)C(2)]taurine (3.1 +/- 0.2 micromol x kg(‐1) x h(‐1))
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Bolus injection of [(13)C(2)]taurine (3.0 +/- 0.1 micromol/kg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Continuous infusion of tracer
Number of subjects: 5
Study: 11604383

Group type: EXPERIMENTAL
Intervention: Self-completion diary
Number of subjects: 0

Group type: COMPARATOR
Intervention: MYMOP2
Number of subjects: 0
Study: 9610692

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (370 mg/m2) plus folinic acid (200 mg/m2) administered daily for 5 days every 4 weeks for 6 cycles
Number of subjects: 888

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 888
Study: 7601177

Group type: EXPERIMENTAL
Intervention: Flurbiprofen LATTM (40 mg) applied via a nonwoven polyester patch every 12 hours for 14 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (patch without active ingredient)
Number of subjects: 80
Study: 3072179

Group type: EXPERIMENTAL
Intervention: autogenic training
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: biofeedback
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: breathing‐relaxation training
Number of subjects: 117

Group type: COMPARATOR
Intervention: psychological placebo
Number of subjects: 117
Study: 29401546

Group type: EXPERIMENTAL
Intervention: Levothyroxine and iodide therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27496717

Group type: EXPERIMENTAL
Intervention: Bioabsorbable screws
Number of subjects: 40

Group type: COMPARATOR
Intervention: Steel screws
Number of subjects: 40
Study: 24029743

Group type: EXPERIMENTAL
Intervention: COPD participants undergoing baseline visit and three annual follow-up examinations with quarterly telephone calls.
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Adjudication of exacerbations and mortality.
Number of subjects: 3200
Study: 23795985

Group type: EXPERIMENTAL
Intervention: IV ranibizumab (0.5 mg, 0.05 cc)
Number of subjects: 48

Group type: COMPARATOR
Intervention: IV bevacizumab (1.5 mg, 0.06 cc)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48

Group type: COMPARATOR
Intervention: IV bevacizumab
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: IV ranibizumab
Number of subjects: 48
Study: 19752567

Group type: EXPERIMENTAL
Intervention: Intranasal lavage with hypertonic saline solution 3 times daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no local therapy)
Number of subjects: 45
Study: 18664346

Group type: EXPERIMENTAL
Intervention: Yiqi Sanju Formula (YQSJF)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 16466005

Group type: EXPERIMENTAL
Intervention: Internal oblique aponeurosis flap (IOAF) repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lichtenstein's tension-free repair
Number of subjects: 0
Study: 12030615

Group type: EXPERIMENTAL
Intervention: 0.25 mg dexamethasone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.5 mg dexamethasone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1.0 mg dexamethasone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Dexamethasone administration at 21:00 h vs 23:00 h
Number of subjects: 6
Study: 10193725

Group type: EXPERIMENTAL
Intervention: Primary percutaneous transluminal coronary angioplasty
Number of subjects: 506
Study: 7605283

Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Peribulbar anesthesia
Number of subjects: 116
Study: 2225504

Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 50
Study: 367255

Group type: EXPERIMENTAL
Intervention: Erythromycin stearate (Resibion) 500 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Erythromycin stearate (Resibion) 250 mg every 6 hours
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enteric-coated erythromycin base (Etromycin) 250 mg every 6 hours
Number of subjects: 16
Study: 31947628

Group type: EXPERIMENTAL
Intervention: Policaptil Gel Retard (PGR)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 29359880

Group type: EXPERIMENTAL
Intervention: High insertion torque (≥50 Ncm)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Regular insertion torque (<50 Ncm)
Number of subjects: 116
Study: 27467038

Group type: EXPERIMENTAL
Intervention: 120-μm cap thickness
Number of subjects: 40

Group type: COMPARATOR
Intervention: 140-μm cap thickness
Number of subjects: 40
Study: 24733648

Group type: EXPERIMENTAL
Intervention: Physiotherapy added to standard treatment (deep breathing exercises, mobilizations, incentive spirometry)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard treatment (medical treatment and drainage)
Number of subjects: 104
Study: 23326136

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 60
Study: 20819541

Group type: EXPERIMENTAL
Intervention: Sucrose gel
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Metronidazole gel
Number of subjects: 560

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 560
Study: 18295798

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Olanzapine (in African American and Hispanic subjects)
Number of subjects: 59
Study: 16466166

Group type: EXPERIMENTAL
Intervention: Fuzheng Huayu Capsule (FHC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (ineffective group)
Number of subjects: 50
Study: 14625122

Group type: EXPERIMENTAL
Intervention: Hormonal Replacement Therapy (HRT)
Number of subjects: 20
Study: 10993129

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 308
Study: 9055715

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg once daily for eight weeks plus amoxycillin 750 mg twice daily for weeks 7 and 8
Number of subjects: 107

Group type: COMPARATOR
Intervention: Omeprazole 40 mg once daily for eight weeks
Number of subjects: 107
Study: 8396084

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for three days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Dicloxacillin 250 mg four times a day for seven days
Number of subjects: 62
Study: 3729711

Group type: EXPERIMENTAL
Intervention: Intravenous ampicillin sodium and metronidazole
Number of subjects: 65

Group type: COMPARATOR
Intervention: Penicillin G sodium, streptomycin, and metronidazole
Number of subjects: 65
Study: 29407540

Group type: EXPERIMENTAL
Intervention: Sertraline plus exercise (S+EX)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Sertraline (S)
Number of subjects: 121
Study: 26725707

Group type: EXPERIMENTAL
Intervention: 100 000 IU of vitamin D3 every 3 months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 000 IU of vitamin D3 every 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 100 000 IU of vitamin D3
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 000 IU of vitamin D3
Number of subjects: 60
Study: 25204412

Group type: EXPERIMENTAL
Intervention: Chemoablation group (CT-guided percutaneous chemical ablation)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Chemoradiation group (additional radiotherapy, second-line chemotherapy, or both)
Number of subjects: 31
Study: 22288725

Group type: EXPERIMENTAL
Intervention: Low-dose azithromycin (250 mg orally daily for 5 days then 2× weekly for a total of 12 weeks)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-dose azithromycin
Number of subjects: 11
Study: 20394966

Group type: EXPERIMENTAL
Intervention: Transvesical prostatectomy (TVP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 80
Study: 18551087

Group type: EXPERIMENTAL
Intervention: Physical exercise and hormone therapy (estradiol valerate 1 mg/d orally)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Physical exercise and placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sedentary and hormone therapy (estradiol valerate 1 mg/d orally)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sedentary and placebo
Number of subjects: 44
Study: 16083524

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 100 mg/kg into the cardiopulmonary bypass prime followed by infusion at 20 mg/kg/h
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11825530

Group type: EXPERIMENTAL
Intervention: Posterior interbody fusion with cage (cage group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Posterolateral lumbar fusion with RF fixation (RF group)
Number of subjects: 32
Study: 9744431

Group type: EXPERIMENTAL
Intervention: ACT only pacing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: QT pacing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ACT = QT pacing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: QT and ACT = QT pacing
Number of subjects: 10
Study: 7913854

Group type: EXPERIMENTAL
Intervention: 80 mg propranolol (PR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (C)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both trials (C and PR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (UB and LB)
Number of subjects: 20
Study: 3256808

Group type: EXPERIMENTAL
Intervention: CLOtest
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Histopathological examination
Number of subjects: 175
Study: 7801609

Group type: EXPERIMENTAL
Intervention: HBV DNA detection using a 32P‐labelled dot blot hybridisation assay
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Serum alanine aminotransferase (ALT) estimation
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Correlation of ALT with HBV DNA positivity
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Normal ALT levels in DNA-positive samples
Number of subjects: 605
Study: 42577

Group type: EXPERIMENTAL
Intervention: Oral prostaglandin E2
Number of subjects: 100

Group type: COMPARATOR
Intervention: Buccal tablets of demoxytocin
Number of subjects: 100
Study: 30673029

Group type: EXPERIMENTAL
Intervention: Palatal appliance (GI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mandibular appliance (GII)
Number of subjects: 20
Study: 29095784

Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate (BMAC) with bone allograft
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bone allograft without BMAC (Control Group)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate (BMAC) with bone allograft (Test Group)
Number of subjects: 10
Study: 26093675

Group type: EXPERIMENTAL
Intervention: People-centered tuberculosis care strategy with educational and counselling sessions, SMS reminders, and phone calls for adherence monitoring.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: People-centered tuberculosis care strategy.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard directly observed treatment strategy (control).
Number of subjects: 0
Study: 23629959

Group type: EXPERIMENTAL
Intervention: CBT‐I with adjunctive IRT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 40
Study: 20401752

Group type: EXPERIMENTAL
Intervention: Enzymatic hydrolysed collagen (EHC) 10 g daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Glucosamine sulphate (GS) 1.5 g
Number of subjects: 100
Study: 19141065

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.025%
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05%
Number of subjects: 35
Study: 17909165

Group type: EXPERIMENTAL
Intervention: Culturally tailored diabetes self-management program
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 17
Study: 15136679

Group type: EXPERIMENTAL
Intervention: Famciclovir
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: Subacute herpetic neuralgia (non-PHN)
Number of subjects: 965
Study: 12790943

Group type: EXPERIMENTAL
Intervention: Open treatment (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Closed treatment (Group B)
Number of subjects: 100
Study: 9727544

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg once daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isosorbide mononitrate (ISMN, 50 mg once daily)
Number of subjects: 24